Nykode Therapeutics AS (NYKD.OL)

NOK 2.59

(15.42%)

Total Assets Summary of Nykode Therapeutics AS

  • Nykode Therapeutics AS's latest annual total assets in 2023 was 2.11 Billion USD , down -3.09% from previous year.
  • Nykode Therapeutics AS's latest quarterly total assets in 2024 Q2 was 179.87 Million USD , down -6.26% from previous quarter.
  • Nykode Therapeutics AS reported annual total assets of 2.18 Billion USD in 2022, down -6.83% from previous year.
  • Nykode Therapeutics AS reported annual total assets of 2.34 Billion USD in 2021, up 18.9% from previous year.
  • Nykode Therapeutics AS reported quarterly total assets of 2.08 Billion USD for 2024 Q1, down -7.83% from previous quarter.
  • Nykode Therapeutics AS reported quarterly total assets of 2.11 Billion USD for 2023 FY, down -3.09% from previous quarter.

Annual Total Assets Chart of Nykode Therapeutics AS (2023 - 2016)

Created with Highcharts 11.1.0YearsTotal Assets201620172018201920202021202220230 NOK500000000 NOK1000000000 NOK1500000000 NOK2000000000 NOK2500000000 NOK3000000000 NOK

Historical Annual Total Assets of Nykode Therapeutics AS (2023 - 2016)

Year Total Assets Total Assets Growth
2023 2.11 Billion USD -3.09%
2022 2.18 Billion USD -6.83%
2021 2.34 Billion USD 18.9%
2020 1.96 Billion USD 571.33%
2019 293.37 Million NOK 91.32%
2018 153.33 Million NOK -28.5%
2017 214.46 Million NOK -14.9%
2016 252 Million NOK 0.0%

Peer Total Assets Comparison of Nykode Therapeutics AS

Name Total Assets Total Assets Difference
Arctic Bioscience AS 300.25 Million NOK -604.164%
Aqua Bio Technology ASA 34.42 Million NOK -6040.851%
ArcticZymes Technologies ASA 339.32 Million NOK -523.083%
BerGenBio ASA 174.33 Million NOK -1112.76%
Hofseth BioCare ASA 390.11 Million NOK -441.954%
PCI Biotech Holding ASA 44.05 Million NOK -4699.692%
Thor Medical ASA 330.83 Million NOK -539.069%
Ultimovacs ASA 349.03 Million NOK -505.739%